Evidence map›Paper›PMID 40909970›Full record

ArticleFrontiers in oncology2025

Ischemic stroke of undetermined source as a priming event for brain metastasis: a case report and systematic literature review.

Paolo Amisano, Antonio Ciacciarelli, Svetlana Lorenzano, Irene Berto, Sara Belcastro, Danilo Toni, Manuela De Michele

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paolo AmisanoDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Antonio CiacciarelliStroke Unit, Emergency Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Svetlana LorenzanoDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Irene BertoStroke Unit, Emergency Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Sara BelcastroDepartment of Radiological Sciences, Oncology and Pathology, I.C.O.T. Hospital, Sapienza University of Rome, Latina, Italy.
Danilo ToniDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Manuela De MicheleStroke Unit, Emergency Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between ischemic stroke (IS) and malignancy is well established. Cancer-related strokes are predominantly embolic and classified as embolic strokes of undetermined source (ESUS). While malignancy-associated coagulopathy represents the primary pathogenic mechanism, neoplastic embolization of circulating tumor cells is another potential etiology, particularly in cases of cardiac and pulmonary malignancies. We report the case of a 58-year-old man who presented with ESUS and concurrent multiple pulmonary nodules. Despite a comprehensive oncologic evaluation, including an ultrasound-guided bronchoscopic biopsy of the suspected lesion, no malignancy was detected. Several months later, the patient developed focal seizures, and brain magnetic resonance imaging (MRI) revealed multiple left frontoparietal space-occupying lesions with imaging features suggestive of brain metastases (BMs). A follow-up whole-body computed tomography (CT) scan confirmed a right upper lobe lung mass, which was diagnosed as pulmonary adenocarcinoma on subsequent mediastinal lymph node biopsy. The ischemic event may have contributed to the subsequent development of BMs through neoplastic embolization, allowing malignant cells to proliferate within the ischemic brain parenchyma. Alternatively, the stroke may have resulted from cancer-associated coagulopathy. In this context, post-stroke pathophysiological changes-including blood-brain barrier (BBB) disruption, neuroinflammation, hypoxia-induced angiogenesis, and extracellular matrix (ECM) remodeling-may have created a permissive microenvironment for tumor cell seeding and colonization, definable as a "pre-metastatic niche". ESUS can be the initial clinical manifestation of an undiagnosed malignancy, and IS itself may facilitate tumor dissemination, ultimately leading to BMs. This case underscores the importance not only of a thorough oncologic workup in patients with ESUS, but also of a strict neuroradiological follow-up, as a delayed diagnosis of cancer-related stroke may allow malignancy progression, significantly worsening the prognosis and limiting therapeutic options.

Indexed as

brain metastases (BMS)cancer-associated coagulopathycancer-related strokeembolic stroke of undetermined source (ESUS)neoplastic embolismpre-metastatic niche

Identifiers

PMID40909970
PMCPMC12405217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.